WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1632972 PLYMOUTH, MN

Back to KNSA Full portfolio

Position in KNSA

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$1,310,911

+$339,196 QoQ

Shares Held

20,499

+1.6% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 13 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 1.497634030928338.ToString("F0")% Shared 0.ToString("F0")% None 98.50236596907166.ToString("F0")%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $45,863,285 across 32 Drug Manufacturers - Specialty & Generic names. KNSA ranks #5 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	71,595	$12,066,621
2	UTHR	UNITED THERAPEUTICS Corp	16,933	$9,174,807
3	ZTS	Zoetis Inc.	83,719	$6,016,047
4	VTRS	Viatris Inc	362,617	$5,758,357
5	KNSA	Kiniksa Pharmaceuticals International, plc This page	20,499	$1,310,911
6	AMRX	Amneal Pharmaceuticals, Inc.	59,123	$1,023,419
7	IRWD	Ironwood Pharmaceuticals Inc	219,445	$923,863
8	LNTH	Lantheus Holdings, Inc.	7,760	$860,894

All Filings in KNSA

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,310,911	20,499	+1.6%	Shares	Sole	2026-07-15
2026-03-31	$971,715	20,181	+22.9%	Shares	Sole	2026-04-08
2025-12-31	$677,490	16,424	+4.9%	Shares	Sole	2026-01-08
2025-09-30	$607,805	15,653	+1.6%	Shares	Sole	2025-10-29
2025-06-30	$426,394	15,410	+13.6%	Shares	Sole	2025-07-10
2025-03-31	$301,256	13,564	—	Shares	Sole	2025-04-16
No filing history on record for this holder in this stock.